TEVA WOMEN'S HEALTH, INC. INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISON OF BARR PHARMACEUTICALS, INC. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for TEVA WOMEN'S HEALTH, INC. INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISON OF BARR PHARMACEUTICALS, INC.

Sort by

Viewing results 1‒25 of 241836

Novo Nordisk AS
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
...The company is aiming to develop a wide range of drugs and use its manufacturing scale to stay ahead of pharmaceutical rivals seeking to profit from consumer “hype” for weight loss products, he added....
March 8, 2024
Biotech
Drugmakers race to find alternative suppliers as US cracks down on Chinese biotech
...BeiGene said it was “finalising a second source of API outside of China” as part of a process that began in 2019. Eli Lilly and Vertex declined to comment on the talks....
April 11, 2024
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
Novo Nordisk AS
Novo to use Ozempic and Wegovy windfall to invest $7bn a year by 2030
...with a pharmaceutical services asset, an area in which it has other investments....
February 12, 2024
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
April 9, 2024
Eli Lilly & Co
Eli Lilly weight-loss drug found to address sleep apnoea in trial
...Tirzepatide is part of a new class of weight-loss drugs, known as GLP-1s, which includes Novo Nordisk’s Wegovy and Ozempic drugs, that are projected to expand to a $100bn market by the end of the decade,...
April 17, 2024
John Thornhill
Can 23andMe reinvent itself as a drug discovery company?
...Nowadays, it has become ridiculously cheap and easy to discover your own DNA. Spit into a tube, post it to a lab and a genetics testing company will email you the results for as little as $99....
April 4, 2024
FT Live
FT Women in Business Summit
Power and parity: Rewriting the rules for the future
Tuesday, 11 JuneLondon Marriott Hotel Grosvenor Square, Grosvenor Square, London, UK
Pablo Escobar
‘Pablo Escobar’ cannot be registered as a trademark, EU court rules
...Escobar Inc, a company set up by his brother Roberto, had filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) to register “Pablo Escobar” as a trademark for goods and...
April 17, 2024
Covid-19 vaccines
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
...The jab was late to market and suffered from collapsing demand as governments withdrew from procurement deals. The group had a market value of $600mn, as of market close on Friday....
April 15, 2024
LexPharmaceuticals sector
Bayer’s break-up looks inevitable Premium content
...The German conglomerate continues to nurse a giant hangover from its disastrous $63bn takeover of Monsanto agreed in 2016....
February 28, 2024
Corporate bonds
Reading small print for fun and profit
...Yield was hard to find and cash was abundant, so borrowers’ lawyers were able to take the offensive, as a general rule....
March 7, 2024
Johnson & Johnson Co Inc
Johnson & Johnson buys device maker Shockwave for $13.1bn
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
April 5, 2024
News in-depthDrugs research
The race to develop the next generation of weight-loss drugs
...As more treatments come to market, some worry that societies will become too reliant on them, to the detriment of public health measures. It is a view rejected by Holst....
April 1, 2024
Pharmaceuticals sector
Lab monkey prices plunge in China as drug research slows
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
March 1, 2024
Covid-19 vaccines
Moderna puts plans for African vaccine plant on hold
...US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest in pandemic preparedness in Africa have dropped down the agenda as sales of Covid-19 jabs decline...
April 11, 2024
LexLuxury goods
Gucci’s slump means the end of the luxury megatrend Premium content
...Investors, meanwhile, no longer have the luxury of buying into a megatrend. It is time to consider each brand’s prospects individually. camilla.palladino@ft.com...
March 21, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Jayasree K Iyer
There are far too many avoidable deaths in childbirth
...If we as a society are serious about women’s rights, then pharmaceutical companies and the wider global health community must ensure that mothers in the 21st century have a better chance than Kaveri of bringing...
January 17, 2024
LexAstraZeneca PLC
A decade after Pfizer, AstraZeneca needs to find its growth again
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
April 1, 2024
Disease control and prevention
First mass malaria vaccination campaign begins in Africa
...Children in Cameroon will begin receiving malaria vaccines as part of a rollout of the medicine developed by UK pharmaceutical company GSK in up to 12 countries across sub-Saharan Africa....
January 22, 2024
LexPharmaceuticals sector
China will be a huge market for weight-loss drugs Premium content
...Shares of Huadong Medicine and Hua Medicine are down a quarter in the past year, along with a broader slump in the sector as stocks normalise following a pandemic surge....
March 20, 2024
Jennifer Dixon
An election manifesto for the NHS — and a healthy economy
...Investing in social care will be crucial to success. A chunk of our population equivalent in size to Greater Manchester is not working due to ill health: this is a huge and avoidable cost....
April 18, 2024
The Big Read
The next pandemic is coming. Will we be ready?
...He admits to concerns about the global political atmosphere, but argues that it is in everyone’s interests to prepare better for the inevitable next global health calamity....
April 4, 2024
News in-depthEli Lilly & Co
Eli Lilly races to boost capacity as it rolls out rival to Novo Nordisk weight-loss drug
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
March 5, 2024
Behind the Money podcast17 min listen
Can WeightWatchers survive the Wegovy era?
...Clip from Lionsgate Television For further reading: WeightWatchers faces an era when weight loss comes in a syringe Behold the Ozempic effect on business The race to develop the next generation of weight-loss...
April 10, 2024
Brexit
Brexit has ‘exacerbated’ UK drug shortages, research finds
...These price concessions increased from 20 instances per month before 2016 to a peak of 199 per month in late 2022....
April 17, 2024
Biotech
Investors pile into psychedelic drug start-ups tackling mental health
...in women....
February 10, 2024

Previous pagePage 1 of 9674Next page